Equities Analysts Set Expectations for ASPEN PHARMACAR/ADR’s FY2020 Earnings (OTCMKTS:APNHY)

ASPEN PHARMACAR/ADR (OTCMKTS:APNHY) – Analysts at Jefferies Financial Group issued their FY2020 earnings per share (EPS) estimates for shares of ASPEN PHARMACAR/ADR in a research note issued on Thursday, December 5th. Jefferies Financial Group analyst J. Vane-Tempest expects that the company will post earnings per share of $0.88 for the year. Jefferies Financial Group currently has a “Hold” rating on the stock. Jefferies Financial Group also issued estimates for ASPEN PHARMACAR/ADR’s FY2021 earnings at $0.90 EPS, FY2022 earnings at $0.95 EPS and FY2023 earnings at $1.00 EPS.

Several other research analysts have also recently commented on APNHY. Zacks Investment Research cut ASPEN PHARMACAR/ADR from a “hold” rating to a “sell” rating in a research report on Monday, November 18th. ValuEngine upgraded shares of ASPEN PHARMACAR/ADR from a “sell” rating to a “hold” rating in a research note on Saturday.

Shares of APNHY stock opened at $7.43 on Monday. ASPEN PHARMACAR/ADR has a 12 month low of $4.14 and a 12 month high of $11.36. The stock has a 50 day moving average of $7.54 and a two-hundred day moving average of $6.56.

ASPEN PHARMACAR/ADR Company Profile

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty, branded, and generic pharmaceutical products worldwide. The company offers various oral solid dose, liquids, semi-solids, steriles, biogicals, active pharmaceutical ingredients, and infant nutritional products.

Featured Story: Momentum Investing

Receive News & Ratings for ASPEN PHARMACAR/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASPEN PHARMACAR/ADR and related companies with MarketBeat.com's FREE daily email newsletter.